New research targets immune system vulnerabilities

August 5, 2016 by John Diconsiglio, George Washington University
A cluster of CD8 ‘Killer’ T-cells defending the body against a cancer cell. Credit: George Washington University

In the battle against infections and diseases, from AIDS to cancer to diabetes, T-cells are the human body's first line of defense.

The act like soldiers searching out and destroying invading bacteria, viruses and parasites. Vital to our immune systems, T- not only find and kill , but also create antibodies, naturally eradicate and remember germs our bodies encountered decades ago.

But even the strongest armies sometimes find themselves under siege.

When autoimmune diseases and viral infections attack our bodies, they thrive by targeting T-cells—either killing them, disrupting their performance or causing an imbalance in their ranks. With weakened or depleted T-cells, humans can be left virtually defenseless against potentially fatal assaults.

A new study led by Associate Professor of Physics Weiqun Peng may go a long way toward helping our natural defenders and reinforcing damaged T-cell systems.

In a paper published in the journal Nature Immunology, Dr. Peng, along with fourth-year Ph.D. student Zhouhao Zeng and immunologists from the University of Iowa, have unlocked part of the mystery behind T-cell identification—how individual T-cells determine what their functions will be.

The discovery is an important step toward designing drugs that can correct a depletion or imbalance of T-cells and may help the body's defense against autoimmune diseases like AIDS.

"Many diseases operate by perturbing the balance between distinct types of T-cells," Dr. Peng said. "By understanding how these cells are formed, we may, in theory, be able to manipulate T-cell creation and combat autoimmune diseases."

Helpers and Killers

T-cells are broadly divided into two different categories: helper cells (also called CD4), which coordinate the immune response to invading infections, and (or CD8), which actually destroy infected cells to fight off illnesses.

Helper cells send out chemical messages, alerting the that a virus has been detected. The helper cells instruct the killer cells to make copies of themselves, creating a CD8 army that seeks out and eliminates infected cells.

There are 25 million to one billion T-cells in the body. Humans need both helper and killer cells to maintain a healthy immune system.

A normal ratio is about one helper cell for every four killer cells. People with tend to have an increased helper cell to killer cell ratio, while those with viral infections have a decreased ratio.

Until now, researchers had yet to fully decipher what factors controlled the identity of T-cells—essentially how a cell "decided" whether it would be a helper or killer.

Dr. Peng's team revealed that a complex interplay of proteins called transcription factors is the most vital component in establishing individual T-cell identity.

"Think of transcription factors as switches that turn 'on' or 'off' the genes in our cells," Dr. Peng said.

Different kinds of cells have different transcription patterns (known as gene expression), making genes more or less active. In the case of T-cells, Dr. Peng's research found that two specific transcription factors—called Tcf1 and Lef1—switched genes "on" and "off" in a pattern that maintained the identity of killer cells.

If that on/off pattern is disrupted, the cells instead become like . The researchers found that this feat depends on a previously unknown function of these transcription factors. They have intrinsic enzyme-related activities that can directly influence the epigenetic make-up of cells.

"This significant discovery is a new perspective on gene regulation," said Mr. Zeng, who has worked on the T-cell project since 2014 as a research assistant in Dr. Peng's lab.

"Obviously, CD4 and CD8 play important roles in our immune systems. If something goes wrong in the CD4/CD8 mix, our ability to fight off infections and diseases is compromised.

"But if biomedical scientists can develop strategies to turn on/off the T-cell differentiation pathway, we might be able to make drugs that hit the molecular target" and reinforce our immune systems.

A computational biophysicist, Dr. Peng's role in the project involved analyzing the enormous troves of high-throughput sequencing data generated from experiments conducted by his University of Iowa counterparts. The results of their collaborative research came "as a complete surprise," Dr. Peng said, since, according to conventional wisdom, and epigenetic regulators were always thought to be separate entities.

After examining numerous scenarios, Dr. Peng concluded that Tcf1 and Lef1 were the unexpected determining factors that contain their own epigenetic regulators.

"There were no other options," he said. "We eliminated all of the possible solutions. When you discount the possible, the only option left is the impossible—or at least what we once thought was impossible."

Explore further: New study finds CD4 T-Cell and Blimp-1 protein critical to toxoplasmosis regulation

Related Stories

New study finds CD4 T-Cell and Blimp-1 protein critical to toxoplasmosis regulation

August 1, 2016
New research critical to treatment for chronic toxoplasmosis, one of the most common parasitic diseases worldwide, was published in the Journal of Experimental Medicine. Researchers from the George Washington University (GW) ...

Candida-specific helper T cells are preferential and early targets of HIV

June 9, 2016
Candida yeasts normally live on human skin and mucous membranes without causing disease. In individuals with a weakened immune system, however, they are a major cause of opportunistic infections. A study published on June ...

How to rescue the immune system: Study could lead to novel therapy for cancer

February 26, 2012
In a study published in Nature Medicine, Loyola researchers report on a promising new technique that potentially could turn immune system killer T cells into more effective weapons against infections and possibly cancer.

New clues found to immune system's misfiring in autoimmune diseases

June 2, 2016
A person's genetic makeup plays a role in autoimmune diseases such as multiple sclerosis that develop when the body is attacked by its own immune system. But little is known about how immune cells are pushed into overdrive.

Harnessing the 'Natural Killer' within us to fight cancer

May 23, 2016
Our bodies are constantly and successfully fighting off the development of cells that lead to tumours - but when there is disruption to this process cancer is free to develop.

Immune cell 'switch' discovery raises hopes in cancer fight

February 26, 2016
The immune cells, called natural killer cells, hunt and destroy foreign cells in the body, including cancer cells that spread and form tumours.

Recommended for you

Researchers identify source of molecule linked to nasal polyps, asthma attacks

May 23, 2018
A new discovery about how the immune system responds to common sinus infections and asthma could explain why patients develop these issues in the first place and ultimately may lead to improved targeted therapies. Researchers ...

Study demonstrates new treatment for severe asthma

May 22, 2018
Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat ...

Eczema drug effective against severe asthma

May 21, 2018
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies. Dupilumab, an injectable ...

Neuron guidance factor found to play a key role in immune cell function

May 21, 2018
Macrophages are white blood cells involved in a variety of biological functions, from destroying infectious pathogens to repairing damaged tissue. To carry out their different roles, macrophages must first be activated and ...

Immune cells hold promise in slowing down ALS

May 21, 2018
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive ...

First clues to the causes of multiple sclerosis

May 16, 2018
Multiple sclerosis, which affects one in 1,000 people, is frequently characterised by relapses associated with variable functional impairments including among others vision problems, impairment of locomotor functions or difficulties ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.